Correlation Between Milestone Pharmaceuticals and Quoin Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Milestone Pharmaceuticals and Quoin Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Milestone Pharmaceuticals and Quoin Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Milestone Pharmaceuticals and Quoin Pharmaceuticals Ltd, you can compare the effects of market volatilities on Milestone Pharmaceuticals and Quoin Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Milestone Pharmaceuticals with a short position of Quoin Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Milestone Pharmaceuticals and Quoin Pharmaceuticals.
Diversification Opportunities for Milestone Pharmaceuticals and Quoin Pharmaceuticals
-0.1 | Correlation Coefficient |
Good diversification
The 3 months correlation between Milestone and Quoin is -0.1. Overlapping area represents the amount of risk that can be diversified away by holding Milestone Pharmaceuticals and Quoin Pharmaceuticals Ltd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Quoin Pharmaceuticals and Milestone Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Milestone Pharmaceuticals are associated (or correlated) with Quoin Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Quoin Pharmaceuticals has no effect on the direction of Milestone Pharmaceuticals i.e., Milestone Pharmaceuticals and Quoin Pharmaceuticals go up and down completely randomly.
Pair Corralation between Milestone Pharmaceuticals and Quoin Pharmaceuticals
Given the investment horizon of 90 days Milestone Pharmaceuticals is expected to generate 1.21 times more return on investment than Quoin Pharmaceuticals. However, Milestone Pharmaceuticals is 1.21 times more volatile than Quoin Pharmaceuticals Ltd. It trades about 0.3 of its potential returns per unit of risk. Quoin Pharmaceuticals Ltd is currently generating about -0.48 per unit of risk. If you would invest 143.00 in Milestone Pharmaceuticals on August 30, 2024 and sell it today you would earn a total of 44.00 from holding Milestone Pharmaceuticals or generate 30.77% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 95.65% |
| Values | Daily Returns |
Milestone Pharmaceuticals vs. Quoin Pharmaceuticals Ltd
Performance |
| Timeline |
| Milestone Pharmaceuticals |
| Quoin Pharmaceuticals |
Milestone Pharmaceuticals and Quoin Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Milestone Pharmaceuticals and Quoin Pharmaceuticals
The main advantage of trading using opposite Milestone Pharmaceuticals and Quoin Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Milestone Pharmaceuticals position performs unexpectedly, Quoin Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Quoin Pharmaceuticals will offset losses from the drop in Quoin Pharmaceuticals' long position.The idea behind Milestone Pharmaceuticals and Quoin Pharmaceuticals Ltd pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Quoin Pharmaceuticals vs. Ikena Oncology | Quoin Pharmaceuticals vs. Eliem Therapeutics | Quoin Pharmaceuticals vs. HCW Biologics | Quoin Pharmaceuticals vs. RenovoRx |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |